Claritin account

$83 MILLION CLARITIN AD ACCOUNT MOVED TO EURO RSCG:

Schering-Plough Corp. has changed agencies on its over-the-counter allergy medication Claritin, giving the $83 million account to Havas' Claritin ad account moves from Ogilvy & Mather to Euro RSCG Worldwide, New York, executives close to the business said.

Schering-Plough spent $83 million in measured media on Claritin last year, according to TNS Media Intelligence/CMR. The company has spent $35.5 million on the allergy medicine through the first four months of this year, putting it on par to spend $106.5 million for the year.

Advertising Age reported in June that Schering-Plough had launched a review to consolidate its $400 million global advertising budget at one or two holding companies. Claritin is its premier over-the-counter product, and Euro RSCG already handles several OTC products for Schering-Plough, including Lotrimin, Dr. Scholl's and Coppertone.